Determinants of influenza immunization uptake in Canadian youths

Vaccine

Volumn 28, Issue 19, 2010, Pages 3462-3466

  Li, Zhuo ^a   Doan, Quynh ^b   Dobson, Simon ^b  

^a CHILDREN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adolescent; Influenza; Pediatrics; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ALCOHOL CONSUMPTION; ALLERGY; ARTICLE; CANADA; CHILD; CHRONIC DISEASE; CROSS-SECTIONAL STUDY; DRINKING BEHAVIOR; EGG ALLERGY; FEMALE; HEALTH CARE UTILIZATION; HEALTH STATUS; HEALTH SURVEY; HUMAN; IMMIGRANT; IMMIGRATION; INFLUENZA; INFLUENZA VACCINATION; JUVENILE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SMOKING;

ADOLESCENT; CANADA; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IMMUNIZATION; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PATIENT ACCEPTANCE OF HEALTH CARE;

EID: 77950519176     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.02.068     Document Type: Article

References (25)

1. Influenza (Seasonal). Available at: http://www.who.int/mediacentre/factsheets/fs211/en/.
2. Influenza immunization - "the flu shot". Available at: http://www. phac-aspc.gc. ca/im/iif-vcg/index-eng.php.
3. Beran J., Vesikari T., Wertzova V., Karvonen A., Honegr K., Lindblad N., et al. Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial. J Infect Dis 200 12 (2009 Dec 15) 1861-1869
4. Piedra P.A., Gaglani M.J., Riggs M., Herschler G., Fewlass C., Watts M., et al. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial. Pediatrics 116 September (3) (2005) e397-e407
5. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360 (2009) 2605-2615
6. Fraser C., Donnelly C.A., Cauchemez S., Hanage W.P., Van Kerkhove M.D., Hollingsworth T.D., et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science 324 (2009) 1557-1561
7. Influenza. Red Book; 2006. pp. 408-409.
8. Holm M.V., Blank P.R., and Szucs T.D. Trends in influenza vaccination coverage rates in Germany over five seasons from 2001 to 2006. BMC Infect Dis 7 (2007) 144
9. Blank P.R., Schwenkglenks II M., and Szucs T.D. Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC Public Health 8 (2008) 272 doi:10.1186/1471-2458r-r8-272
10. Centers for Disease Control and Prevention (CDC). National vaccination coverage among adolescents aged 13-17 years-United States, 2006. MMWR Morb Mortal Wkly Rep 56 August 31 (34) (2007) 885-888
11. Johansen H., Sambell C., and Zao X. Flu shots-national and provincial territorial trends. Health Rep 17 2 (2006) 43-48
12. Chen Y., Yi Q.-L., Wu J., and Li F. Chronic disease status, self-perceived health and hospital admissions are important predictors for having a flu shot in Canada. Vaccine 25 (2007) 7436-7440
13. Moran K., Maaten S., Guttmann A., Northrup D., and Kwongb J.C. Influenza vaccination rates in Ontario children: implications for universal childhood vaccination policy. Vaccine 27 (2009) 2350-2355
14. Pearson W.S., Dube S.R., Ford E.S., and Mokdad A.H. Influenza and pneumococcal vaccination rates among smokers: data from the 2006 behavioral risk factor surveillance. Syst Prev Med 48 (2009) 180-183
15. Müller D., and Szucs T.D. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05. Infection 35 October (5) (2007) 308-319
16. Choudhri Y., and Walop W. Influenza vaccine-associated adverse events: results of passive surveillance, Canada 2001-2002. Can Commun Dis Rep 28 December 1 (23) (2002) 189-196
17. Espositoa S., Gasparinia C., Martelli b A., Zengab A., Tremolatia E., Varina E., et al. Safe administration of an inactivated virosomal adjuvanted influenza vaccine in asthmatic children with egg allergy. Vaccine 26 (2008) 4664-4668
18. Kelso J.M. Update on vaccination guidelines for allergic children. Expert Rev Vaccines 8 11 (2009) 1541-46(6)
19. Jiménez-García R., Hernández-Barrera V., Carrasco-Garrido P., de Andrés A.L., Pérez N., and de Miguel A.G. Influenza vaccination coverages among children, adults, health care workers and immigrants in Spain: related factors and trends, 2003-2006. J Infect 57 (2008) 472-480
20. Jiménez-García R., Hernández-Barrera V., Carrasco-Garrido P., Popez de Andres A., Esteban y Peña M.M., and Gil de Miguel A. Coverage and predictors of influenza vaccination among adults living in a large metropolitan area in Spain: a comparison between the immigrant and indigenous populations. Vaccine 26 33 (2008) 4218e23
21. Mac Donald R., Baken L., Nelson A., and Nichol K.L. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med 16 3 (1999) 173-177
22. Zimmerman R.K., Raymund M., Janosky J.E., Nowalk M.P., and Fine M.J. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine 21 13-14 (2003) 1486-1491
23. Prosser L.A., Bridges C.B., and Uyeki T.M. Values for preventing influenza-related morbidity and vaccine adverse events in children. Health and Quality of Life Outcomes 3 (2005) 18
24. Steiner M., Vermeulen L.C., Mullahy J., and Hayney M.S. Factors influencing decisions regarding influenza vaccination and treatment: a survey of healthcare workers. Infect Control Hosp Epidemiol 23 October (10) (2002)
25. Esposito S., Marchisio P., and Principi N. The global state of influenza in children. Pediatr Infect Dis J 27 11 Suppl. (2008 November) S149-S153